Illumina (ILMN) Other Non-Current Assets (2010 - 2026)
Illumina's (ILMN) quarterly Other Non-Current Assets came in at $576.0 million in Q2 2026, up 44.0% on a YoY basis from $400.0 million in Q2 2025, and up 10.13% quarter-over-quarter from $523.0 million in Q1 2026.
Analysis
Illumina (ILMN) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Illumina (ILMN) has reported Other Non-Current Assets for 17 consecutive years, with $576.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Assets rose 44.0% year-over-year to $576.0 million; the trailing twelve-month figure through Jun 2026 stood at $576.0 million (up 44.0% YoY), and the FY2025 full-year result was $449.0 million, up 29.02% from the prior year.
- Other Non-Current Assets improved to $576.0 million in Q2 2026 per ILMN's latest filing, from $523.0 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $576.0 million in Q2 2026 and bottomed at $314.0 million in Q2 2024.
- Historically, Other Non-Current Assets has averaged $423.3 million across 5 years, with a median of $423.0 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Other Non-Current Assets tumbled 40.61% in 2022, then surged 44.0% in 2026.
- Over 5 years, Other Non-Current Assets stood at $448.0 million in 2022, then slipped by 20.31% to $357.0 million in 2023, then decreased by 2.52% to $348.0 million in 2024, then advanced by 29.02% to $449.0 million in 2025, then gained by 28.29% to $576.0 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $576.0 million, $523.0 million, and $449.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 5.62 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 4.39 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 1.07 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 576.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 309.11 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 264.34 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 101.70 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 4.05 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 15.31 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 816.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 576.00 Mn |
| Mar 29, 2026 | 523.00 Mn |
| Dec 28, 2025 | 449.00 Mn |
| Sep 28, 2025 | 423.00 Mn |
| Jun 29, 2025 | 400.00 Mn |
| Mar 30, 2025 | 373.00 Mn |
| Dec 29, 2024 | 348.00 Mn |
| Sep 29, 2024 | 321.00 Mn |
| Jun 30, 2024 | 314.00 Mn |
| Mar 31, 2024 | 458.00 Mn |
| Dec 31, 2023 | 357.00 Mn |
| Oct 1, 2023 | 439.00 Mn |
| Jul 2, 2023 | 417.00 Mn |
| Apr 2, 2023 | 423.00 Mn |
| Jan 1, 2023 | 423.00 Mn |
| Oct 2, 2022 | 448.00 Mn |
| Jul 3, 2022 | 449.00 Mn |
| Apr 3, 2022 | 457.00 Mn |
| Jan 2, 2022 | 445.00 Mn |
| Oct 3, 2021 | 478.00 Mn |